Efficacy and safety of sacubitril/valsartan (LCZ696) in reducing adverse cardiovascular events and controlling hypertension among asians: a meta-analysis of randomised controlled trials
Event:
Heart Failure 2022
Topic:
Cardiovascular Pharmacotherapy
Session:
Heart Failure ePosters - focus on Pharmacology and other topics